Immunic | VTL - Betriebsaufwand

Aktienkurs
1.19
Täglich Wechseln
0.09 8.18%
Monatlich
32.47%
Jährlich
1.71%
Q1 Prognose
1.07




Betriebsaufwand Veränderung Datum
Alterity Therapeutics Limited AUD 7.78M 3M 2023-06
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Cipla INR 60.98B 1.06B 2025-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Enanta Pharmaceuticals USD 126.59M 346.51M 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Immunic USD 25.73M 2.91M 2024-09
Insmed USD 513.55M 109.86M 2025-12
Omeros USD 59.16M 20.13M 2024-06
OraSure Technologies USD 40.35M 2.45M 2025-12
Quidel USD 760.9M 1.28B 2025-12
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
United Therapeutics USD 804.8M 5.79B 2025-12
Xoma USD 22.84M 1.67M 2024-09